| Date | Name | Shares | Transaction | Value |
|
Mar 5, 2026
| John J. Engel Chairman, President & CEO |
478,907
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Mar 5, 2026
| Daniel J. Castillo EVP & GM, EES |
3,827
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Mar 5, 2026
| Daniel J. Castillo EVP & GM, EES |
13,900
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Mar 5, 2026
| Laura K. Thompson Director |
10,984
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Mar 5, 2026
| Laura K. Thompson Director |
10,325
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $289.5 per share |
2,989,087.50
|
|
Mar 5, 2026
| Glynis A. Bryan Director |
4,112
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Mar 5, 2026
| David C. Wajsgras Director |
659
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Mar 5, 2026
| James Louis Singleton Director |
39,610
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Mar 5, 2026
| Steven A. Raymund Director |
25,469
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Mar 5, 2026
| Steven A. Raymund Director |
24,810
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $289.5 per share |
7,182,495.00
|
|
Mar 5, 2026
| John J. Engel Chairman, President & CEO |
20,143
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Mar 5, 2026
| Bobby J. Griffin Director |
32,132
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Mar 5, 2026
| John J. Engel Chairman, President & CEO |
470,456
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $289.5 per share |
136,197,012.00
|
|
Mar 5, 2026
| Christine Ann Wolf EVP & CHRO |
2,216
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Mar 5, 2026
| Christine Ann Wolf EVP & CHRO |
30,411
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Mar 5, 2026
| Christine Ann Wolf EVP & CHRO |
29,481
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $289.5 per share |
8,534,749.50
|
|
Mar 5, 2026
| Diane E. Lazzaris EVP and General Counsel |
2,820
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Mar 5, 2026
| Diane E. Lazzaris EVP and General Counsel |
29,516
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Mar 5, 2026
| Diane E. Lazzaris EVP and General Counsel |
28,333
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $289.5 per share |
8,202,403.50
|
|
Mar 5, 2026
| Matthew J. Espe Director |
21,375
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|